Clinical Trial Update: Dose Escalation and PK Study of M2ES in Subjects With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 dose-escalation and pharmacokinetics study of the investigational drug M2ES in subjects with solid tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• M2ES

Snippet

Sponsor: Protgen Ltd | Conditions: Advanced Solid Tumors | Phase 1 | Status: UNKNOWN